 |
 |
Thanks for the info. Lorraine Jeffe Wilson DeCamp <[log in to unmask]> wrote: In a message dated 4/17/2007 2:08:47 A.M. Eastern Daylight Time, [log in to unmask] writes: I think that Teva in Israel developed Requip. They also developed the dopamine patch that has been approved in Europe. Have no idea what the status of the patch is with the FDA,does anyone?Has anyone had access to it? Possibly been part of a trial. Any info on status, etc would be appreciated.. Lorraine Jeffe Lorraine, Requip (ropinirole) was developed in the US by GlaxoSmithKline. They are currently studying a sustained release (once daily) formulation. Teva was apparently involved with overseas development and marketing. I don't know anything about a dopamine patch being developed in the US. However, a rotigotine patch is under development by Schwarz Pharma. Based on company statements, approval is expected later this year. You can get a lot of information about these, as well as other PD treatments, that are in the development pipeline at http://www.pdpipeline.org/. This is a free database that we try to keep up-to-date. Wilson DeCamp a member of the pipeliners ************************************** See what's free at http://www.aol.com. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn